메뉴 건너뛰기




Volumn 62, Issue 16, 2013, Pages 1432-1435

Complete revascularization: A quality-performance metric?

Author keywords

complete revascularization coronary artery bypass graft coronary artery disease meta analysis percutaneous coronary intervention

Indexed keywords

EVEROLIMUS; PACLITAXEL;

EID: 84885454803     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.05.034     Document Type: Editorial
Times cited : (7)

References (21)
  • 1
    • 84871311607 scopus 로고    scopus 로고
    • 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: A report of the American College of Cardiology Foundation
    • S.D. Fihn, J.M. Gardin, and J. Abrams 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/ STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons J Am Coll Cardiol 60 2012 e44 164
    • (2012) J Am Coll Cardiol , vol.60 , pp. 44-164
    • Fihn, S.D.1    Gardin, J.M.2    Abrams, J.3
  • 2
    • 77958128969 scopus 로고    scopus 로고
    • Guidelines on myocardial revascularization
    • for the Task Force on Myocardial Revascularization of the ESC and EACTS, EAPCI
    • W. Wijns, P. Kohl, N. Danchin for the Task Force on Myocardial Revascularization of the ESC and EACTS, EAPCI Guidelines on myocardial revascularization Eur Heart J 31 2010 2501 2555
    • (2010) Eur Heart J , vol.31 , pp. 2501-2555
    • Wijns, W.1    Kohl, P.2    Danchin, N.3
  • 3
    • 58249113934 scopus 로고    scopus 로고
    • Incomplete revascularization in the era of drug-eluting stents: Impact on adverse outcomes
    • E.L. Hannan, C. Wu, and G. Walford Incomplete revascularization in the era of drug-eluting stents: impact on adverse outcomes J Am Coll Cardiol Intv 2 2009 17 25
    • (2009) J Am Coll Cardiol Intv , vol.2 , pp. 17-25
    • Hannan, E.L.1    Wu, C.2    Walford, G.3
  • 4
    • 79958133646 scopus 로고    scopus 로고
    • Impact of angiographic complete revascularization after drug-eluting stent implantation or coronary artery bypass graft surgery for multivessel coronary artery disease
    • Y.H. Kim, D.W. Park, and J.Y. Lee Impact of angiographic complete revascularization after drug-eluting stent implantation or coronary artery bypass graft surgery for multivessel coronary artery disease Circulation 123 2011 2373 2381
    • (2011) Circulation , vol.123 , pp. 2373-2381
    • Kim, Y.H.1    Park, D.W.2    Lee, J.Y.3
  • 5
    • 84885452143 scopus 로고    scopus 로고
    • Outcomes after complete versus incomplete revascularization of patients with multivessel coronary artery disease: A meta-analysis of 89,883 patients enrolled in randomized clinical trials and observation studies
    • S. Garcia, Y. Sandoval, and H. Roukoz Outcomes after complete versus incomplete revascularization of patients with multivessel coronary artery disease: a meta-analysis of 89,883 patients enrolled in randomized clinical trials and observation studies J Am Coll Cardiol 62 2013 1421 1431
    • (2013) J Am Coll Cardiol , vol.62 , pp. 1421-1431
    • Garcia, S.1    Sandoval, Y.2    Roukoz, H.3
  • 6
    • 84861867540 scopus 로고    scopus 로고
    • Quantification and impact of untreated coronary artery disease after percutaneous coronary intervention: The residual SYNTAX (Synergy between PCI with Taxus and Cardiac Surgery) score
    • P. Généreux, T. Palmerini, and A. Caixeta Quantification and impact of untreated coronary artery disease after percutaneous coronary intervention: the residual SYNTAX (Synergy Between PCI with Taxus and Cardiac Surgery) score J Am Coll Cardiol 59 2012 2165 2174
    • (2012) J Am Coll Cardiol , vol.59 , pp. 2165-2174
    • Généreux, P.1    Palmerini, T.2    Caixeta, A.3
  • 7
    • 84878317732 scopus 로고    scopus 로고
    • Residual SYNTAX score after PCI for triple vessel coronary artery disease: Quantifying the adverse effect of incomplete revascularisation
    • C.J. Malkin, V. George, and M.S. Ghobrial Residual SYNTAX score after PCI for triple vessel coronary artery disease: quantifying the adverse effect of incomplete revascularisation EuroIntervention 8 2013 1286 1295
    • (2013) EuroIntervention , vol.8 , pp. 1286-1295
    • Malkin, C.J.1    George, V.2    Ghobrial, M.S.3
  • 8
    • 84883231998 scopus 로고    scopus 로고
    • Objectifying the impact of incomplete revascularization by repeat angiographic risk assessment with the residual SYNTAX score after left main coronary artery percutaneous coronary intervention
    • D. Capodanno, A. Chisari, and D. Giacoppo Objectifying the impact of incomplete revascularization by repeat angiographic risk assessment with the residual SYNTAX score after left main coronary artery percutaneous coronary intervention Catheter Cardiovasc Interv 82 2013 333 340
    • (2013) Catheter Cardiovasc Interv , vol.82 , pp. 333-340
    • Capodanno, D.1    Chisari, A.2    Giacoppo, D.3
  • 9
    • 84861453872 scopus 로고    scopus 로고
    • Incidence, predictors and outcomes of incomplete revascularization after percutaneous coronary intervention and coronary artery bypass grafting: A subgroup analysis of 3-year SYNTAX data
    • S.J. Head, M.J. Mack, and D.R. Holmes Jr. Incidence, predictors and outcomes of incomplete revascularization after percutaneous coronary intervention and coronary artery bypass grafting: a subgroup analysis of 3-year SYNTAX data Eur J Cardiothorac Surg 41 2012 535 541
    • (2012) Eur J Cardiothorac Surg , vol.41 , pp. 535-541
    • Head, S.J.1    MacK, M.J.2    Holmes, Jr.D.R.3
  • 10
    • 84871313275 scopus 로고    scopus 로고
    • Strategies for multivessel revascularization in patients with diabetes
    • for the FREEDOM Trial Investigators
    • M.E. Farkouh, M. Domanski, L.A. Sleeper for the FREEDOM Trial Investigators Strategies for multivessel revascularization in patients with diabetes N Engl J Med 367 2012 2375 2384
    • (2012) N Engl J Med , vol.367 , pp. 2375-2384
    • Farkouh, M.E.1    Domanski, M.2    Sleeper, L.A.3
  • 11
    • 84859819731 scopus 로고    scopus 로고
    • Comparative effectiveness of revascularization strategies
    • W.S. Weintraub, M.V. Grau-Sepulveda, and J.M. Weiss Comparative effectiveness of revascularization strategies N Engl J Med 366 2012 1467 1476
    • (2012) N Engl J Med , vol.366 , pp. 1467-1476
    • Weintraub, W.S.1    Grau-Sepulveda, M.V.2    Weiss, J.M.3
  • 12
    • 80053337086 scopus 로고    scopus 로고
    • Impact of the everolimus-eluting stent on stent thrombosis: A meta-analysis of 13 randomized trials
    • U. Baber, R. Mehran, and S.K. Sharma Impact of the everolimus-eluting stent on stent thrombosis: a meta-analysis of 13 randomized trials J Am Coll Cardiol 58 2011 1569 1577
    • (2011) J Am Coll Cardiol , vol.58 , pp. 1569-1577
    • Baber, U.1    Mehran, R.2    Sharma, S.K.3
  • 13
    • 84862128532 scopus 로고    scopus 로고
    • Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: A mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials
    • S. Bangalore, S. Kumar, and M. Fusaro Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials Circulation 125 2012 2873 2891
    • (2012) Circulation , vol.125 , pp. 2873-2891
    • Bangalore, S.1    Kumar, S.2    Fusaro, M.3
  • 14
    • 79959508607 scopus 로고    scopus 로고
    • Randomized comparison of everolimus- and paclitaxel-eluting stents: 2-year follow-up from the SPIRIT (Clinical Evaluation of the XIENCE v Everolimus Eluting Coronary Stent System) IV trial
    • for SPIRIT IV Investigators
    • G.W. Stone, A. Rizvi, K. Sudhir for SPIRIT IV Investigators Randomized comparison of everolimus- and paclitaxel-eluting stents: 2-year follow-up from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) IV trial J Am Coll Cardiol 58 2011 19 25
    • (2011) J Am Coll Cardiol , vol.58 , pp. 19-25
    • Stone, G.W.1    Rizvi, A.2    Sudhir, K.3
  • 15
    • 80051733441 scopus 로고    scopus 로고
    • Predictors of death or myocardial infarction, ischaemic-driven revascularisation, and major adverse cardiovascular events following everolimus-eluting or paclitaxel-eluting stent deployment: Pooled analysis from the SPIRIT II, III, IV, and COMPARE trials
    • D.J. Kereiakes, P.C. Smits, and E. Kedhi Predictors of death or myocardial infarction, ischaemic-driven revascularisation, and major adverse cardiovascular events following everolimus-eluting or paclitaxel-eluting stent deployment: pooled analysis from the SPIRIT II, III, IV, and COMPARE trials EuroIntervention 7 2011 74 83
    • (2011) EuroIntervention , vol.7 , pp. 74-83
    • Kereiakes, D.J.1    Smits, P.C.2    Kedhi, E.3
  • 16
    • 78651424782 scopus 로고    scopus 로고
    • Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients undergoing multilesion and multivessel intervention: The SPIRIT III
    • D.J. Kereiakes, K. Sudhir, and J.B. Hermiller Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients undergoing multilesion and multivessel intervention: the SPIRIT III (A Clinical Evaluation of the Investigational Device XIENCE V Everolimus Eluting Coronary Stent System [EECSS] in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) and SPIRIT IV (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) randomized trials J Am Coll Cardiol Intv 3 2010 1229 1239
    • (2010) J Am Coll Cardiol Intv , vol.3 , pp. 1229-1239
    • Kereiakes, D.J.1    Sudhir, K.2    Hermiller, J.B.3
  • 17
    • 77956513678 scopus 로고    scopus 로고
    • Would SYNTAX have been a positive trial if XIENCE v had been used instead of TAXUS? A meta-analysis of a first-generation vs. a second-generation drug-eluting stent system
    • B.E. Claessen, G.W. Stone, and P.C. Smits Would SYNTAX have been a positive trial if XIENCE V had been used instead of TAXUS? A meta-analysis of a first-generation vs. a second-generation drug-eluting stent system Neth Heart J 18 2010 451 453
    • (2010) Neth Heart J , vol.18 , pp. 451-453
    • Claessen, B.E.1    Stone, G.W.2    Smits, P.C.3
  • 18
    • 77955066802 scopus 로고    scopus 로고
    • Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study
    • N.H. Pijls, W.F. Fearon, and P.A. Tonino Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study J Am Coll Cardiol 56 2010 177 184
    • (2010) J Am Coll Cardiol , vol.56 , pp. 177-184
    • Pijls, N.H.1    Fearon, W.F.2    Tonino, P.A.3
  • 19
    • 80052991610 scopus 로고    scopus 로고
    • Impact of intravascular ultrasound imaging on early and late clinical outcomes following percutaneous coronary intervention with drug-eluting stents
    • B.E. Claessen, R. Mehran, and G.S. Mintz Impact of intravascular ultrasound imaging on early and late clinical outcomes following percutaneous coronary intervention with drug-eluting stents J Am Coll Cardiol Intv 4 2011 974 981
    • (2011) J Am Coll Cardiol Intv , vol.4 , pp. 974-981
    • Claessen, B.E.1    Mehran, R.2    Mintz, G.S.3
  • 20
    • 80051789392 scopus 로고    scopus 로고
    • What is the role of complex coronary anatomy in modern bypass surgery? Lessons learned from the SYNTAX trial after two years
    • May 1 to 5 Toronto, Ontario, Canada
    • Mohr FW, Rastan M, Serruys PW, et al. What is the role of complex coronary anatomy in modern bypass surgery? Lessons learned from the SYNTAX trial after two years. Paper presented at: 90th Annual Meeting of the American Association of Thoracic Surgeons, May 1 to 5, 2010; Toronto, Ontario, Canada.
    • (2010) 90th Annual Meeting of the American Association of Thoracic Surgeons
    • Mohr, F.W.1    Rastan, M.2    Serruys, P.W.3
  • 21
    • 84868616890 scopus 로고    scopus 로고
    • Complete versus incomplete revascularization with coronary artery bypass graft or percutaneous intervention in stable coronary artery disease
    • M. Gössl, D.P. Faxon, M.R. Bell, D.R. Holmes, and B.J. Gersh Complete versus incomplete revascularization with coronary artery bypass graft or percutaneous intervention in stable coronary artery disease Circ Cardiovasc Interv 5 2012 597 604
    • (2012) Circ Cardiovasc Interv , vol.5 , pp. 597-604
    • Gössl, M.1    Faxon, D.P.2    Bell, M.R.3    Holmes, D.R.4    Gersh, B.J.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.